Figure 2
From: Kinetics of plasma cfDNA predicts clinical response in non-small cell lung cancer patients
Comparison of cfDNA levels and cfDNA ratio between the responsive group and non-responsive group. Boxplots from top to bottom showed the baseline value (A), post-therapy value (B), and ratio value (C) of cfDNA respectively in both the responsive (PR/CR, N = 56) group and non-responsive (PD/SD, N = 80) group, the significance of difference between the two was estimated by Wilcoxon test.
